Browse > Article
http://dx.doi.org/10.5352/JLS.2003.13.4.463

Characterization of tryptophan residues of human coagulation factor V required for binding to phospholipid membranes  

Kim, Suhng-Wook (Clinical Laboratory Science, College of Health Sciences, Korea University)
Publication Information
Journal of Life Science / v.13, no.4, 2003 , pp. 463-472 More about this Journal
Abstract
Interactions between factor Va (HFVa) and membrane phosphatidylserine (PS) regulate the activity of the prothrombinase complex. I have previously shown that two solvent exposed hydrophobic residues located in the C2-domain, Trp2063 and Trp2064, are required for binding to immobilized PS and for expression of procoagulant activity on membranes containing 5% PS. In order to fully define the functional importance of these two residues I have expressed and isolated recombinant factor Va (rHFVa) W2063A/W2064A double mutant. In contrast to the native protein the two glycoforms resulting from alternative glycosylation of Asn2181 eluted as a single peak with rHFVa1 W2063A/W2064A eluting on the leading edge and rHFVa2 W2063A/W2064A eluting on the trailing edge. The double mutant rHFVa2 W2063A/W2064A expressed little or no procoagulant activity on membranes containing 1-10% mol % PS. In contrast, the procoagulant activity of this mutant was slightly greater than the native protein on membranes containing>18 mol % PS. The binding of rHFVa2 W2063A/W2064A to immobilized phospholipid vesicles was markedly reduced compared to the native protein in a surface plasmon resonance binding assay. I conclude that Trp2063 and Trp2064 are required for high affinity binding of factor Va to PS membranes and that this interaction is necessary for assembly of the prothrombinase complex on membranes containing physiological concentrations of PS.
Keywords
human coagulation factor V; membrane binding;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kalafatis, M., R. J. Jenny and K. G. Mann. 1990. Identification and characterization of a phospholipidbinding site of bovine factor Va. J. Biol. Chem. 265, 21580-21589.
2 Ortel, T. L., M. A. Quinn-Allen, L. A. Charles, D. Devore-Carter and W. H. Kane. 1992. Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity. J. Clin. Invest. 90, 2340-2347.   DOI
3 Lecompte, M. F., S. Krishnaswamy, K. G. Mann, M. E. Nesheim and C. Gitler. 1987. Membrane penetration of bovine factor V and Va detected by labeling with 5-iodonaphthalene-1-azide. J. Biol. Chem. 262, 1935-1937.
4 Rosing, J., H. M. Bakker, M. C. L. G. D. Thomassen, H. C. Hemker and G. Tans. 1993. Characterization of two forms of human factor Va with different cofactor activities. J. Biol. Chem. 268, 21130-21136.
5 Mann, K. G., M. E. Nesheim, W. R. Church, P. Haley and S. Krishnaswamy. 1990. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1-16.
6 Higgins, D. L. and K. G. Mann. 1983. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J. Biol. Chem. 258, 6503-6508.
7 Kalafatis, M., M. D. Rand and K. G. Mann. 1994. Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry 33, 486-493.   DOI   ScienceOn
8 Kane, W. H. and E. W. Davie. 1988. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71, 539-555.
9 Pratt, K. P., B. W. Shen, K. Takeshima, E. W. Davie, K. Fujikawa and B. L. Stoddard. 1999. Structure of the C2 domain of human factor VIII at 1.5 $\AA$ resolution. Nature 402, 439-442.   DOI   ScienceOn
10 Pusey, M. L., L. D. Mayer, G. J. Wei, V. A. Bloomfield and G. L. Nelsestuen. 1982. Kinetic and hydrodynamic analysis of blood clotting factor V-membrane binding. Biochemistry. 21, 5262-5269.   DOI   ScienceOn
11 Pellequer, J. L., A. J. Gale, J. H. Griffin and E. D. Getzoff. 1998. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol Dis 24, 448-461.   DOI   ScienceOn
12 Nicolaes, G. A., B. O. Villoutreix and B. Dahlback. 1999. Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Biochemistry 38, 13584-13591.   DOI   ScienceOn
13 Zwaal, R. F., P. Comfurius and E. M. Bevers. 1998. Lipid-protein interactions in blood coagulation. Biochim Biophys Acta 1376, 433-453.   DOI   ScienceOn
14 Kim, S. W., T. L. Ortel, M. A. Quinn-Allen, L. Yoo, L. Worfolk, X. Zhai, B. R. Lentz and W. H. Kane. 1999. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex. Biochemistry 38, 11448-11454.   DOI   ScienceOn
15 Bardelle, C., B. Furie, B. C. Furie and G. E. Gilbert. 1993. Membrane binding kinetics of factor VIII indicate a complex binding process. J. Biol. Chem. 268, 8815-8824.
16 Macedo-Ribeiro, S., W. Bode, R. Huber, M. A. Quinn-Allen, S. W. Kim, T. L. Ortel, G. P. Bourenkov, H. D. Bartunik, M. T. Stubbs, W. H. Kane and P. Fuentes-Prior. 1999. Crystal structures of the membranebinding C2 domain of human coagulation factor V. Nature 402, 434-439.   DOI   ScienceOn
17 Kim, S. W., M. A. Quinn-Allen, T. Camp, S. Macedo-Ribeiro, P. Fuentes-Prior, W. Bode and W. H. Kane. 2000. Identification of functionally important amino acid residue within the C2 domain of human factor V using alanine scanning mutagenesis. Biochemistry 39, 1951-1958.   DOI   ScienceOn
18 Krieg, U. C., B. S. Isaacs, S. S. Yemul, C. T. Esmon, H. Bayley and A. E. Johnson. 1987. Interaction of blood coagulation factor Va with phospholipid vesicles examined by using lipophilic photoreagents. Biochemistry. 26, 103-109.   DOI   ScienceOn
19 Koppaka, V., W. F. Talbot, X. Zhai and B. R. Lentz. 1997. Roles of factor Va heavy and light chains in protein and lipid rearrangements associated with the formation of a bovine factor Va-membrane complex. Biophys. J. 73, 2638-2652.   DOI   ScienceOn
20 Hoekema, L., G. A. F. Nicolaes, H. C. Hemker, G. Tans and J. Rosing. 1997. Human Factor Va1 and Factor Va2: Properties in the Procoagulant and Anticoagulant Pathways. Biochemistry 36, 3331-3335.   DOI   ScienceOn
21 Srivastava, A., M. A. Quinn-Allen, S. W. Kim, W. H. Kane and B. R. Lentz. 2001. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va. Biochemistry 40, 8246-8255.   DOI   ScienceOn
22 Tracy, P. B. and K. G. Mann. 1983. Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va. Proc. Natl. Acad. Sci. U. S. A. 80, 2380-2384.   DOI   ScienceOn
23 Pusey, M. L. and G. L. Nelsestuen. 1984. Membrane binding properties of blood coagulation Factor V and derived peptides. Biochemistry. 23, 6202-6210.   DOI   ScienceOn
24 Ortel, T. L., M. A. Quinn-Allen, F. G. Keller, J. A. Peterson, D. Larocca and W. H. Kane. 1994. Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras. J. Biol. Chem. 269, 15898-15905.
25 van de Waart, P., H. Bruls, H. C. Hemker and T. Lindhout. 1983. Interaction of bovine blood clotting factor Va and its subunits with phospholipid vesicles. Biochemistry. 22, 2427-2432.   DOI   ScienceOn
26 Nicolaes, G. A., B. O. Villoutreix and B. Dahlback. 2000. Mutations in a potential phospholipid binding loop in the C2 domain of factor V affecting the assembly of the prothrombinase complex. Blood Coagul. Fibrinolysis 11, 89-100.   DOI
27 Ortel, T. L., D. Devore-Carter, M. A. Quinn-Allen and W. H. Kane. 1992. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain. J. Biol. Chem. 267, 4189-4198.
28 Ortel, T. L., K. D. Moore, M. A. Quinn-Allen, T. Okamura, A. J. Sinclair, J. Lazarchick, R. Govindan, F. Carmagnol and W. H. Kane. 1998. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations. Blood 91, 4188-4196.
29 Krishnaswamy, S. and K. G. Mann. 1988. The binding of factor Va to phospholipid vesicles. J. Biol. Chem. 263, 5714-5723.